John K. Clarke

Director, MOMENTA PHARMACEUTICALS INC.

Companies

aTyr PharmaBoard member May 6, 2015 to May 23, 2024¹
Alnylam PharmaceuticalsBoard member Jun 2, 2006 to Jun 22, 2018²
Verastem OncologyBoard member Jan 26, 2012 to Jun 13, 2013³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

aTyr Pharma ATYR19,797 shares⁴$3.4K at $0.17Apr 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 26, 2023Exercised options 6,000 shares of aTyr Pharma⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARaTyr Pharma, Board member
2
SEC EDGARAlnylam Pharmaceuticals, Board member
3
SEC EDGARVerastem Oncology, Board member
4
SEC EDGARaTyr Pharma shares after the filing of Apr 26, 2023